Related by context. All words. (Click for frequent words.) 73 subclinical hypothyroidism 72 macroalbuminuria 71 albuminuria 70 T2DM 70 PSADT 70 subclinical hyperthyroidism 69 diabetes mellitus DM 68 MetS 68 Hb A1C 68 subclinical atherosclerosis 68 impaired fasting glucose 68 glomerular filtration rate 68 glycated hemoglobin 68 glycated hemoglobin levels 68 cardiovascular mortality 68 renal dysfunction 68 HbA1c levels 68 PCa 67 proteinuria 67 cystatin C 67 glycosylated hemoglobin 67 glomerular filtration 67 overt nephropathy 67 advanced adenoma 67 nonfatal MI 67 HbA 1c 67 serum creatinine levels 66 NAFLD 66 ADPKD 66 primary aldosteronism 66 left ventricular hypertrophy 66 eGFR 66 serum creatinine 66 alanine aminotransferase ALT 66 T1DM 66 serum testosterone 66 elevated triglyceride levels 66 carotid IMT 66 hyperglycaemia 66 carotid intima media 66 gallstone disease 66 coronary artery calcification 66 serum IGF 66 T2D 66 coronary calcification 66 asymptomatic carotid stenosis 66 albumin excretion rate 66 nephropathy 66 estimated glomerular filtration 66 HGPIN 66 hepatic steatosis 65 beta blocker therapy 65 fasting glucose levels 65 cTnT levels 65 intact parathyroid hormone 65 OGTT 65 Proteinuria 65 carotid stenosis 65 colorectal adenoma 65 prostate cancer CaP 65 atherogenic dyslipidemia 65 impaired glucose tolerance 65 adenoma 65 serum PSA 65 specific antigen PSA 65 troponin T 65 NT proBNP 65 subclinical 65 nonfasting triglyceride levels 65 advanced adenomas 65 diabetes mellitus 65 elevated CRP 65 diabetes mellitus T2DM 65 serum phosphate 65 β blockers 65 alanine aminotransferase 65 thromboembolic 65 CrCl 65 systolic hypertension 65 LV dysfunction 65 estimated GFR 65 glycosylated hemoglobin HbA1c 65 hemoglobin A1c HbA1c 65 mild cognitive impairment 65 silent myocardial ischemia 65 elevated ALT 64 glucose intolerance 64 nondiabetics 64 thyroglobulin 64 arterial stiffness 64 abdominal adiposity 64 recurrent VTE 64 HOMA IR 64 nonalcoholic steatohepatitis NASH 64 mL/min/#.# m 2 64 lowest tertile 64 prospectively defined 64 creatinine levels 64 elevated triglycerides 64 vertebral fracture 64 LQTS 64 fasting plasma glucose 64 pCR 64 serum potassium 64 oral glucose tolerance 64 left ventricular dysfunction 64 hematuria 64 aminotransferases 64 thyrotropin 64 hemoglobin A1c levels 64 tumor recurrence 64 CK MB 64 cTnT 64 CVD mortality 64 intima media thickness 64 posttransplant 64 macrovascular disease 64 serum calcium 64 HbA1c 64 serum urate levels 64 serum vitamin D 64 serum uric acid 64 dysfunction LVSD 64 familial AF 64 advanced neoplasia 64 POAG 64 adenomatous polyps 64 transferrin saturation 64 myocardial ischemia 64 univariate analyzes 64 #.#ng/ml 64 HSCT 63 left ventricular systolic 63 fasting insulin 63 hydroxyvitamin D levels 63 platelet reactivity 63 albumin excretion 63 cerebrovascular events 63 renal artery stenosis 63 rs# [002] 63 Prehypertension 63 Microalbuminuria 63 SCr 63 biochemical recurrence 63 thyrotropin levels 63 definite stent thrombosis 63 hyperkalemia 63 thickness CIMT 63 lipid levels 63 tHcy 63 aminotransferase levels 63 autonomic dysfunction 63 microvascular complications 63 preoperatively 63 HbA 1c levels 63 metabolic acidosis 63 creatinine 63 retinopathy 63 EDSS score 63 C reactive protein 63 NIHSS score 63 glycated hemoglobin HbA1c 63 aortic regurgitation 63 thyroid dysfunction 63 disease progression 63 QTc 63 A1c levels 63 elevated LDL cholesterol 63 systolic dysfunction 63 NGAL 63 rheumatoid factor 63 preserved ejection fraction 63 Lp PLA2 63 mIU L 63 bronchial hyperresponsiveness 63 postoperative complication 63 metabolic syndrome 63 urinary albumin excretion 63 lipid abnormalities 63 polyp recurrence 63 HbA1C 63 fasting triglycerides 63 endothelial dysfunction 63 metabolic syndrome MetS 63 STRIDE PD 63 baseline HbA1c 63 myocardial infarction MI 63 microvascular disease 63 overt hypothyroidism 63 creatinine clearance 63 elevated uric acid 63 prehypertension 63 coronary artery calcium 63 transaminase levels 63 dysglycemia 62 ipsilateral stroke 62 serum aminotransferase levels 62 depressive symptomatology 62 Subgroup analyzes 62 nonalcoholic steatohepatitis 62 microbleeds 62 creatinine ratio 62 hepatorenal syndrome 62 atypical ductal hyperplasia 62 atherothrombotic 62 coronary artery disease 62 kidney dysfunction 62 colorectal neoplasia 62 hypercalciuria 62 extrapyramidal symptoms 62 comorbid conditions 62 cerebral infarction 62 renal function 62 anti JCV antibodies 62 serum ferritin 62 serum lipid levels 62 SGPT 62 confidence interval #.#-#.# 62 paroxysmal AF 62 thyroid stimulating hormone 62 LVEF 62 periprocedural 62 hypoxemia 62 peptide BNP 62 microscopic hematuria 62 nondiabetic patients 62 atherosclerotic disease 62 % CI #.#-#.# [006] 62 Haptoglobin 62 coronary heart 62 urinary albumin 62 AAT deficiency 62 hippocampal atrophy 62 glycemia 62 serum cholesterol 62 fasting blood glucose 62 proliferative diabetic retinopathy 62 antihypertensive therapy 62 leukocyte count 62 cardiac dysfunction 62 artery stenosis 62 urine albumin 62 elevated serum creatinine 62 elevated homocysteine 62 D dimer 62 elevated IOP 62 VT VF 62 AST ALT 62 cognitive impairment 62 vitamin D insufficiency 62 APOE e4 62 μmol L 62 hypercalcemia 62 albumin creatinine ratio 62 intensive statin therapy 62 CHD mortality 62 thromboembolic events 62 thromboembolism 62 liver histology 62 hyperparathyroidism 62 abnormal lipid 62 NNT = 62 QTc prolongation 62 fasting glucose 62 NYHA functional class 62 PSA nadir 62 cardiac troponin T 62 CC genotype 62 amnestic MCI 62 hemoglobin A1C 62 antibody titer 62 proliferative retinopathy 62 serum cortisol 62 morphometric vertebral fractures 62 insulin resistance 62 airway hyperresponsiveness 62 hyperglycemia 62 asymptomatic 62 androgen deficiency 62 CTEPH 62 atrophic gastritis 62 nonobstructive CAD 62 ng mL 62 decompensated heart failure 62 serum calcium levels 61 cirrhotic patients 61 asthma exacerbation 61 macrovascular 61 LUTS 61 colorectal cancer CRC 61 PAOD 61 serum sodium 61 nonadherence 61 severe hypoglycemia 61 echocardiographic 61 serum glucose 61 seropositivity 61 prognostic significance 61 aminotransferase ALT 61 nonvertebral fractures 61 prolactin levels 61 IDDM 61 de ath 61 arterial thromboembolic events 61 serum estradiol 61 GH deficiency 61 lipoprotein levels 61 virologic failure 61 HIV HCV coinfected 61 nonfasting triglycerides 61 highest tertile 61 hypertensives 61 oral antidiabetic medication 61 urinary symptoms 61 onset diabetes mellitus 61 chlamydial infection 61 adenomas 61 ATACAND 61 hypoglycemic episodes 61 EXJADE 61 CMV infection 61 PSA velocity 61 hs CRP 61 serum testosterone levels 61 poor metabolizers 61 renal impairment 61 endometrial hyperplasia 61 colorectal polyps 61 hypovitaminosis D 61 urate levels 61 elevated fasting glucose 61 lactate dehydrogenase LDH 61 hypertensive patients 61 Crohn Disease Activity 61 MGUS 61 coronary revascularization 61 QTc interval 61 Nesiritide 61 renal insufficiency 61 sUA 61 urine NGAL 61 adenoma recurrence 61 aspartate aminotransferase AST 61 APOE genotype 61 left ventricular LV 61 preoperative PSA 61 serum triglycerides 61 prostate cancer PCa 61 MMSE scores 61 serum phosphorus 61 EDSS scores 61 elevated blood glucose 61 thyrotoxicosis 61 A1C levels 61 LV hypertrophy 61 elevated creatinine 61 thyroxine 61 postoperative AF 61 hyperhomocysteinemia 61 LV ejection fraction 61 CIN2 + 61 virological response 61 myocardial infarctions 61 pulmonary exacerbations 61 hydroxyvitamin D 61 hyperuricemia 61 serum GGT 61 prediabetes 61 comorbidity 61 μg dL 61 stable angina 61 prolonged QT interval 61 systolic BP 61 diabetic nephropathy 61 Inhibin B 61 serum urate 61 cardioembolic stroke 61 Lp PLA 2 61 amyloid deposition 61 sCJD 61 sinus rhythm 61 protein excretion 61 bone resorption 61 biochemical relapse 61 diabetic kidney 61 Hp2 2 60 airflow obstruction 60 uncontrolled asthma 60 SHPT 60 cervical intraepithelial neoplasia 60 androgen deprivation 60 hypertension 60 ventricular tachyarrhythmia 60 cardiovascular morbidity 60 pg mL 60 noncardiac 60 serum prostate 60 ABCB1 60 myocardial infarction stroke 60 % Confidence Interval 60 baseline serum creatinine 60 thrombotic events 60 erythrocyte sedimentation rate 60 silent ischemia 60 reinfarction 60 SLNB 60 perioperative complications 60 lactic acidosis 60 normotensive 60 NYHA class 60 lipid lowering therapy 60 valvular disease 60 nondiabetic 60 renal scarring 60 VADT 60 HBV infection 60 lymph node metastasis 60 diastolic hypertension 60 liver fibrosis 60 dyslipidaemia 60 nmol L 60 prostate carcinogenesis 60 Hypotension 60 noncardiac surgery 60 multivariate logistic regression 60 claudication 60 lipid parameters 60 serum parathyroid hormone 60 rs# [003] 60 lymphocytosis 60 inflammatory markers 60 hyperphenylalaninemia HPA due 60 pericardial effusion 60 mm Hg systolic 60 coronary disease 60 hypokalemia 60 digital rectal examination 60 Ejection Fraction 60 serum triglyceride levels 60 myocardial infarction 60 hypercholesterolemia 60 white matter hyperintensities 60 CI #.#-#.# [001] 60 autoimmune thyroid 60 atherosclerosis 60 perioperative mortality 60 DAS# [002] 60 cardiovascular disease 60 OSAHS 60 HDL2 60 upper gastrointestinal bleeding 60 APOE e4 gene 60 variceal bleeding 60 procalcitonin 60 neurodevelopmental impairment 60 carotid plaque 60 familial hypercholesterolemia 60 isolated systolic hypertension 60 ALT flares 60 clinically detectable 60 serum ALT 60 cardiovascular hospitalization 60 CSF biomarkers 60 atherothrombotic disease 60 ischemic cardiomyopathy 60 prehypertensive 60 NATRECOR ® 60 NP CRNs 60 lobular carcinoma 60 HbA1C levels 60 hemoglobin A1c 60 ejection fractions 60 C Reactive Protein 60 triglyceride levels 60 carotid artery intima media 60 mmol l 60 iPTH 60 HBeAg seroconversion 60 plasma homocysteine 60 cardiometabolic risk 60 Diabetic nephropathy 60 serum phosphorous 60 atheroma volume 60 asymptomatic PAD 60 varices 60 CIN3 60 eplerenone 60 juvenile idiopathic arthritis 60 intracerebral haemorrhage 60 parathyroidectomy 60 Brugada syndrome 60 postoperative mortality 60 amnestic mild cognitive impairment 60 hsCRP 60 undergoing radical prostatectomy 60 neurocognitive deficits 60 cerebrovascular accident 60 testosterone supplementation 60 Sudden Cardiac Death 60 Endothelial dysfunction 60 varicocele 60 HER2 overexpression 60 aspartate aminotransferase 60 graft dysfunction 60 candesartan 60 nonfatal myocardial infarction 60 triglyceride concentrations 60 symptomatic VTE 60 periprocedural MI 60 Asymptomatic 60 NMIBC 60 hsCRP levels 60 BLLs 60 Expanded Disability Status 60 serum concentrations 60 NIH CPSI 60 Prediabetes 60 HBV infections 60 #mmHg [001] 60 virologic response 60 triacylglycerol concentrations 60 undergoing coronary angiography 60 stratifying patients 60 cerebral vasospasm 59 clinically meaningful reductions 59 hepatotoxicity 59 familial ALS 59 % CI #.#-#.# [007] 59 ADAS Cog 59 MADRS score 59 colorectal neoplasms 59 serum leptin 59 complete cytogenetic response 59 antihypertensive medications 59 NATRECOR R 59 Kaplan Meier analysis 59 NHANES III 59 arterial hypertension 59 thyroid nodules 59 spontaneous bacterial peritonitis 59 euthyroid 59 HbF 59 neovascular 59 antigen PSA 59 basal cell nevus syndrome 59 coronary blockages 59 ng ml 59 QTcF 59 Clusterin 59 adrenal function 59 ventricular dysfunction 59 Prostate Specific Antigen PSA 59 hepatic fibrosis 59 univariate analysis 59 epithelial ovarian cancer 59 MMSE score 59 mRNA expression 59 urinary excretion 59 APOC3 59 CDAI score 59 troponins 59 carotid atherosclerosis 59 thrombotic complications 59 abnormal glucose metabolism 59 serum PTH 59 diabetic retinopathy 59 CP CPPS 59 Severe Primary IGFD 59 hematopoietic cancers 59 clinically insignificant 59 distant metastases 59 urinary calcium 59 acetabular dysplasia 59 folate intake 59 inotropic 59 Hashimoto thyroiditis 59 cytopenias 59 HBeAg 59 microalbumin 59 ng dL 59 steatosis 59 ischemic lesions 59 prostate specific antigen 59 statin therapy 59 adiponectin concentrations 59 onset atrial fibrillation 59 Logistic regression analysis 59 recurrent atrial fibrillation 59 elevated LDH 59 paricalcitol 59 polycystic ovary syndrome PCOS 59 torsade de pointes 59 hepatic cirrhosis 59 genetic polymorphisms 59 venous thromboembolism 59 sudden cardiac death 59 HbA 1C 59 octreotide LAR 59 lipid lowering medications 59 exhaled nitric oxide 59 corticosteroid dose 59 mmol L 59 arterial stiffening 59 concomitant medications 59 intravesical therapy 59 anastomotic leak 59 sustained virological response 59 hypomagnesemia 59 mCRC patients 59 XIENCE V PROMUS Stent 59 corneal thickness 59 cryptogenic 59 contrast induced nephropathy 59 endometrial carcinoma 59 HER2 expression 59 cognitive decline 59 endometrial thickness 59 RBP4 59 pulmonary arterial 59 troponin 59 TEAEs 59 Afib 59 APOE gene 59 cTnI 59 CYP#C# [001] 59 apnea hypopnea index 59 serum HCV RNA 59 benign breast 59 metabolic parameters 59 intestinal polyps 59 bioavailable testosterone 59 hemodilution 59 comorbidities 59 coronary stenosis 59 recurrent wheezing 59 Acute renal failure 59 Epidemiologic studies 59 homocysteine concentrations 59 AA Amyloidosis 59 lispro 59 pheochromocytoma 59 hypogonadal 59 severe neutropenia 59 grade cervical intraepithelial 59 gestational diabetes mellitus 59 2 diabetes T2D 59 recurrent venous thromboembolism 59 fetuin 59 liver transplant recipients 59 transaminase elevations 59 penetrance 59 parkinsonism 59 multivariate Cox 59 recurrent DVT 59 hypoperfusion 59 post thrombotic syndrome 59 plasma glucose 59 triiodothyronine 59 HeFH 59 undetectable HCV RNA 59 adrenalectomy 59 fragility fracture 59 tumor lysis syndrome 59 GSTP1 59 oxygen desaturation 59 postoperative pulmonary 59 SHBG levels 59 ischemic stroke 59 LVSD 59 isoprostane 59 thromboembolic complications 59 distant metastasis 59 cryptogenic stroke 59 pernicious anemia 59 cerebral microbleeds 59 6MWD 59 colorectal adenomas 59 hyperphosphatemia 59 ADHF 59 orthostatic hypotension 59 resistant hypertension 59 HBeAg negative 59 breast carcinoma 59 ApoE4 59 chronic hepatitis cirrhosis 59 insulin resistance syndrome 59 biochemical markers 59 lung function 59 diastolic heart 59 Subarachnoid hemorrhage 59 rs# [004] 59 HNSCC 59 micrometastases 59 adiponectin levels 59 Adenomas 59 echocardiographic parameters 59 co morbidities 59 IgA deficiency 59 cervical carcinoma 59 preoperative chemotherapy 59 ventricular remodeling 59 pelvic lymphadenectomy 59 Prostate Specific Antigen 59 neurocognitive function 59 dopaminergic therapy 59 ertapenem 59 HF hospitalization 59 VaD 59 gastric adenocarcinoma 59 metabolic abnormalities 58 Scale EDSS 58 colorectal carcinoma 58 cognitive dysfunction 58 TP# mutations 58 sinus node dysfunction 58 Insulin resistance 58 recurrent miscarriage 58 aortic valve stenosis 58 neovascular AMD 58 bosentan 58 coronary calcium 58 c reactive protein 58 ximelagatran 58 impaired glucose metabolism 58 bronchopulmonary dysplasia 58 urolithiasis 58 monoclonal gammopathy 58 pioglitazone 58 cognitively normal 58 QT intervals 58 Index CDAI 58 sleep disordered breathing 58 cardiovascular hospitalizations 58 hemorrhagic complications 58 acute myocardial infarction MI 58 antidiabetic medication 58 N telopeptide 58 eNO 58 ASCUS 58 cardiac troponin 58 plasma glucose levels 58 baseline FEV 58 uric acid levels 58 bezafibrate 58 moderate renal impairment 58 neuropsychiatric symptoms 58 F FDG PET 58 flow mediated dilation 58 mammographic density 58 NSTE ACS 58 atherosclerotic lesion 58 noncarriers 58 NYHA Class II 58 hemodynamic instability 58 reflux symptoms 58 K ras mutations 58 Osteopenia 58 progressive dyspnea 58 #mmHg [002] 58 cardiac conduction 58 cryptorchidism 58 metachronous 58 Non Alcoholic Fatty 58 SRBD 58 clusterin 58 hyperinsulinemia 58 nonischemic 58 DMARD 58 renal allograft 58 transaminases 58 SNHL 58 Insulin sensitivity 58 spirometric 58 ACTH 58 natriuretic peptide 58 hematological parameters 58 SGRQ 58 pmol L 58 thyroid stimulating hormone TSH 58 pT3 58 atherothrombosis 58 adiposity 58 plasma lipids 58 KRAS mutation 58 psychiatric comorbidities 58 μg dl 58 BRCA mutations 58 Subgroup analysis 58 hip BMD 58 ICD implantation 58 nmol liter 58 intermittent claudication 58 chronic thromboembolic pulmonary 58 central corneal thickness 58 alteplase 58 gastric carcinoma 58 hypogonadotropic hypogonadism 58 brain shrinkage 58 Nocturia 58 CDAI 58 prediabetic 58 transcranial Doppler ultrasound 58 Cystatin C 58 HNPCC 58 Coronary artery calcification 58 metastatic malignant 58 cardiovascular disease CVD 58 macrovascular events 58 elevated bilirubin 58 metabolic disturbances 58 Impaired glucose tolerance 58 sweat chloride 58 carotid bruit 58 IPAH 58 HPA axis suppression 58 recurrent UTI 58 plasma glucose concentration 58 salmeterol HFA MDI 58 atrioventricular block 58 virological failure 58 myocardial fibrosis 58 postoperative morbidity 58 aneurysmal subarachnoid hemorrhage 58 hemodialysis patients 58 kidney function 58 BENICAR HCT 58 â ‰ ¥ 58 venous thrombosis 58 hepatocellular carcinoma 58 recurrent glioblastoma multiforme 58 fibrosis 58 pretest probability 58 mU L 58 calculated creatinine clearance 58 nonmelanoma skin cancer 58 choroidal neovascularization 58 adenomatous 58 lipid lowering drugs 58 BRAF mutation 58 plasma folate 58 mEq L 58 ≥ 58 reperfusion therapy 58 aortic stiffness 58 ECG abnormalities 58 systemic corticosteroid 58 FDG uptake 58 adrenal insufficiency 58 Erythropoietic therapies may 58 CR nPR 58 LTBI 58 cataract formation 58 HES CEL 58 diabetes dyslipidemia 58 angiotensin receptor blockers ARBs 58 endotoxemia 58 tolvaptan 58 adjunctive ABILIFY 58 antihypertensive medication 58 prognostic factors 58 Natalizumab 58 lumbar spine BMD 58 perimenopausal women 58 BMI ≥ 58 diastolic dysfunction 58 SGOT 58 anemia hemoglobin 58 tuberculin skin testing 58 ventricular arrhythmia 58 glucose tolerance test 58 atypical hyperplasia 58 prognostic variables 58 MACCE 58 multivariable analysis 58 serum BDNF 58 arterial thickening 58 neurologic symptoms 58 telomere lengths 58 lower extremity amputation 58 IFN beta 58 Arch Intern Med 58 pT2 58 airway responsiveness 58 ‰ ¥ 58 visceral adiposity 58 hours postdose 58 neutrophil counts 58 nonobese 58 logistic regression analysis 58 periprosthetic infection 58 Myelodysplastic Syndrome MDS 58 irbesartan 58 candesartan cilexetil 58 hypocalcemia 58 anterior uveitis 58 postoperative atrial fibrillation 58 osteoporotic fracture 58 graft occlusion 58 Hemoglobin A1c 58 brain lesions 58 secondary hyperparathyroidism 58 geographic atrophy 58 coinfected patients 58 residual platelet reactivity 58 antiarrhythmic drug 58 histologically 58 hemolysis 58 bacteriuria 58 ejection fraction 58 multivariate adjustment 58 #.#mmol L [002] 58 logistic regression model 58 neoadjuvant chemotherapy 58 Multivariate analysis 58 sd = 58 adenotonsillectomy 58 differentiated thyroid 58 BENICAR 58 arterial calcification 58 GFR 58 leiomyomas 58 ductal cancer 58 HRQL 58 Prostate specific antigen 58 infarct size 58 IPSS 58 alkaline phosphatase 58 vasopressor 58 primary biliary cirrhosis 58 lactose malabsorption 58 invasive aspergillosis 58 Non Alcoholic Steatohepatitis 58 serum thyroglobulin 58 Response Evaluation Criteria 58 alexithymia 58 severe exacerbations 58 giant cell arteritis 58 HAQ DI 58 liver metastasis 58 intestinal permeability 58 nonsignificant 58 x ULN 58 neoplasm 58 B7 H3 58 mU liter 58 retinal thickness 58 PREZISTA r 58 NNRTI resistance 58 chest radiographs 58 Aß 58 ventricular arrhythmias 58 RYGB 58 #OHD levels 58 postintervention 58 node metastases 58 neurocognitive impairment 58 clinically meaningful improvement 58 acute myelogenous leukemia AML 58 #mg/dL [001] 58 Logistic regression 58 SUVmax 58 nitrotyrosine 58 soluble CD# ligand 57 UA NSTEMI 57 AVODART 57 IGFBP 57 cytogenic 57 NPH insulin 57 umol L 57 serum folate concentrations 57 fatal arrhythmic 57 GnRH agonist 57 fasting plasma glucose FPG 57 acute myocardial infarction AMI 57 timepoints 57 confidence interval CI 57 magnesium intake 57 PaO 2 57 urinary oxalate 57 T2 lesions 57 radiographic progression 57 apolipoprotein B 57 TAXUS p value 57 revascularization procedures 57 Homocysteine 57 pulmonary capillary wedge 57 valvulopathy 57 glycosylated hemoglobin levels 57 histologically confirmed 57 acute aortic dissection 57 premorbid 57 postoperative delirium 57 torsades de pointes 57 VKORC1 57 QRS duration 57 thiazide diuretics 57 BMI z 57 colorectal polyp 57 postprandial hyperglycemia